PMID- 24247044 OWN - NLM STAT- MEDLINE DCOM- 20141201 LR - 20211021 IS - 1740-634X (Electronic) IS - 0893-133X (Print) IS - 0893-133X (Linking) VI - 39 IP - 5 DP - 2014 Apr TI - The BDNF Val66Met polymorphism modulates the generalization of cued fear responses to a novel context. PG - 1187-95 LID - 10.1038/npp.2013.320 [doi] AB - Brain-derived neurotrophic factor (BDNF) has a crucial role in activity-dependent synaptic plasticity and learning and memory. The human functional single-nucleotide BDNF rs6265 (Val66Met) polymorphism has been found to be associated with alteration in neural BDNF release and function correlating with altered emotional behavior. Here, we investigated for the first time the hypothesis that this polymorphism in humans modulates the context dependency of conditioned fear responses. Applying a new paradigm examining generalization of cued fear across contexts, 70 participants stratified for BDNF Val66Met polymorphism were guided through two virtual offices (context) in which briefly illuminated blue and yellow lights served as cues. In the fear context, one light (conditioned stimulus, CS+) but not the other light (CS-) was associated with an electric shock (unconditioned stimulus, US). In the safety context, both lights were presented too, but no US was delivered. During the test phase, lights were presented again both in learning contexts and in a novel generalization context without any US. All participants showed clear fear conditioning to the CS+ in the fear context as indicated by potentiation of startle responses and reports of fear. No fear reactions were found for the CS+ in the safety context. Importantly, generalization of fear responses indicated by the potentiation of startle response to the CS+ compared with the CS- in the novel context was evident only in the Met-carrying group. These are the first results to provide evidence in humans that BDNF modulates the generalization of fear responses. Such context-dependent generalization processes might predispose Met carriers for affective and anxiety disorders. FAU - Muhlberger, Andreas AU - Muhlberger A AD - 1] Department of Psychology (Biological Psychology, Clinical Psychology, and Psychotherapy), University of Wurzburg, Wurzburg, Germany [2] Department of Experimental Psychology (Clinical Psychology and Psychotherapy), University of Regensburg, Regensburg, Germany. FAU - Andreatta, Marta AU - Andreatta M AD - Department of Psychology (Biological Psychology, Clinical Psychology, and Psychotherapy), University of Wurzburg, Wurzburg, Germany. FAU - Ewald, Heike AU - Ewald H AD - Department of Psychology (Biological Psychology, Clinical Psychology, and Psychotherapy), University of Wurzburg, Wurzburg, Germany. FAU - Glotzbach-Schoon, Evelyn AU - Glotzbach-Schoon E AD - Department of Psychology (Biological Psychology, Clinical Psychology, and Psychotherapy), University of Wurzburg, Wurzburg, Germany. FAU - Troger, Christian AU - Troger C AD - Department of Psychology (Biological Psychology, Clinical Psychology, and Psychotherapy), University of Wurzburg, Wurzburg, Germany. FAU - Baumann, Christian AU - Baumann C AD - 1] Department of Psychology (Biological Psychology, Clinical Psychology, and Psychotherapy), University of Wurzburg, Wurzburg, Germany [2] Department of Psychiatry, Psychosomatics, and Psychotherapy, University of Wurzburg, Wurzburg, Germany. FAU - Reif, Andreas AU - Reif A AD - Department of Psychiatry, Psychosomatics, and Psychotherapy, University of Wurzburg, Wurzburg, Germany. FAU - Deckert, Jurgen AU - Deckert J AD - Department of Psychiatry, Psychosomatics, and Psychotherapy, University of Wurzburg, Wurzburg, Germany. FAU - Pauli, Paul AU - Pauli P AD - Department of Psychology (Biological Psychology, Clinical Psychology, and Psychotherapy), University of Wurzburg, Wurzburg, Germany. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20131119 PL - England TA - Neuropsychopharmacology JT - Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology JID - 8904907 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 7171WSG8A2 (BDNF protein, human) SB - IM MH - Adult MH - Anxiety/genetics MH - Brain-Derived Neurotrophic Factor/*genetics MH - *Conditioning, Psychological MH - *Cues MH - Discrimination, Psychological MH - Double-Blind Method MH - Electroshock MH - *Fear MH - Female MH - *Generalization, Psychological MH - Genotype MH - Humans MH - Male MH - Photic Stimulation MH - *Polymorphism, Single Nucleotide MH - Reflex, Startle/genetics MH - Young Adult PMC - PMC3957113 EDAT- 2013/11/20 06:00 MHDA- 2014/12/15 06:00 PMCR- 2015/04/01 CRDT- 2013/11/20 06:00 PHST- 2013/04/01 00:00 [received] PHST- 2013/10/15 00:00 [revised] PHST- 2013/10/16 00:00 [accepted] PHST- 2013/11/20 06:00 [entrez] PHST- 2013/11/20 06:00 [pubmed] PHST- 2014/12/15 06:00 [medline] PHST- 2015/04/01 00:00 [pmc-release] AID - npp2013320 [pii] AID - 10.1038/npp.2013.320 [doi] PST - ppublish SO - Neuropsychopharmacology. 2014 Apr;39(5):1187-95. doi: 10.1038/npp.2013.320. Epub 2013 Nov 19.